Stay updated on Ribociclib and Trametinib in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ribociclib and Trametinib in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The NCT02703571 record is displayed with details about the ribociclib–trametinib study, which was terminated after the sponsor decided not to proceed to Phase II. The page also includes trial design, eligibility, study locations, and measured outcomes.
    Difference
    61%
    Check dated 2026-11-08T03:12:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T23:23:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T23:09:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T23:35:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T23:25:11.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, removing access to the study information while the site chrome (navigation and footer) remains visible.
    Difference
    19%
    Check dated 2026-09-19T22:20:23.000Z thumbnail image

Stay in the know with updates to Ribociclib and Trametinib in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.